wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57628767-2DFABD6C-D441-4DBA-8099-9E13E7B46404
Q57628767-2DFABD6C-D441-4DBA-8099-9E13E7B46404
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57628767-2DFABD6C-D441-4DBA-8099-9E13E7B46404
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial
P2860
Q57628767-2DFABD6C-D441-4DBA-8099-9E13E7B46404
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57628767-2DFABD6C-D441-4DBA-8099-9E13E7B46404
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e71e96210ae6cf4ec3349b69b6ea887fc6f3d5e
P2860
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).